1. Home
  2. THM vs DRUG Comparison

THM vs DRUG Comparison

Compare THM & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Tower Hill Mines Ltd. (Canada)

THM

International Tower Hill Mines Ltd. (Canada)

HOLD

Current Price

$2.47

Market Cap

685.5M

Sector

N/A

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$83.62

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THM
DRUG
Founded
1978
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
685.5M
707.1M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
THM
DRUG
Price
$2.47
$83.62
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$129.25
AVG Volume (30 Days)
1.1M
179.0K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$244.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$23.18
52 Week High
$3.65
$123.75

Technical Indicators

Market Signals
Indicator
THM
DRUG
Relative Strength Index (RSI) 48.75 51.31
Support Level $2.21 $79.55
Resistance Level $2.84 $84.29
Average True Range (ATR) 0.17 5.00
MACD -0.02 -0.78
Stochastic Oscillator 34.37 63.97

Price Performance

Historical Comparison
THM
DRUG

About THM International Tower Hill Mines Ltd. (Canada)

International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project, namely the Livengood Gold Project. It is located in the northwest of Fairbanks, Alaska, in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: